SavedAdd your journal

Journals / Hitit Medical Journal / 2021 / Cilt: 3 - Sayı: 1

The Relationship Between Narrowing Of The QRS Duration And Improvement In The 6-Minute Walking Distance After Cardiac Resynchronization Theraphy

Kardiyak Resenkronizasyon Tedavisi Sonrası 6 Dakikalık Yürüme Mesafesinde İyileşme ile QRS Süresindeki Daralma Arasındaki İlişki

Mert EVLICE
Mustafa AKCAKOYUN
Pages
6–12
Publication Date
2021-02-28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was detected moderate negative correlation (r = -0.52, p < 0.001) between narrowing of the QRS duration and 6-minute walking distance after cardiac resynchronization therapy.Conclusion: In patients with reduced ejection fraction heart failure and cardiac resynchronization therapy, our study has shown that increase in narrowing QRS duration after cardiac resynchronization therapy implantation is associated with development in 6-minute walking distance.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Cardiac resynchronization therapy has been proved to be effective in patients suffering from reduced ejection fraction heart failure related to electrical dyssynchrony.
📊
Key Findings & Data:The aim of this study was to investigate the relationship among narrowing of the QRS duration after cardiac resynchronization therapy and the evaluation of functional capacity by 6-minute walking test.Material and Method: A total of 39 symptomatic (NYHA class II-IV) patients (24 females, 19 males) with chronic heart failure (38% ischemic, 62% non-ischemic) who had left ventricle ejection fraction ≤ 35% were included into the study.Results: The evaluation after cardiac resynchronization therapy revealed statistically significant decrease in QRS duration (153.62 ± 8.49 vs. 131.44 ± 9.86 msec, p < 0.001) and increase in 6-minute walking distance (247.77 ± 52.93 vs. 361.15 ± 66.17 m, p < 0.001) compared to before cardiac resynchronization therapy.
💡
Conclusion & Impact:It was detected moderate negative correlation (r = -0.52, p < 0.001) between narrowing of the QRS duration and 6-minute walking distance after cardiac resynchronization therapy.Conclusion: In patients with reduced ejection fraction heart failure and cardiac resynchronization therapy, our study has shown that increase in narrowing QRS duration after cardiac resynchronization therapy implantation is associated with development in 6-minute walking distance.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:altı dakikalık yürüme testi · Kardiyak resenkronizasyon tedavisi · kronik kalp yetmezliği

Abstract

Objective: Cardiac resynchronization therapy has been proved to be effective in patients suffering from reduced ejection fraction heart failure related to electrical dyssynchrony. The aim of this study was to investigate the relationship among narrowing of the QRS duration after cardiac resynchronization therapy and the evaluation of functional capacity by 6-minute walking test.Material and Method: A total of 39 symptomatic (NYHA class II-IV) patients (24 females, 19 males) with chronic heart failure (38% ischemic, 62% non-ischemic) who had left ventricle ejection fraction ≤ 35% were included into the study.Results: The evaluation after cardiac resynchronization therapy revealed statistically significant decrease in QRS duration (153.62 ± 8.49 vs. 131.44 ± 9.86 msec, p < 0.001) and increase in 6-minute walking distance (247.77 ± 52.93 vs. 361.15 ± 66.17 m, p < 0.001) compared to before cardiac resynchronization therapy. It was detected moderate negative correlation (r = -0.52, p < 0.001) between narrowing of the QRS duration and 6-minute walking distance after cardiac resynchronization therapy.Conclusion: In patients with reduced ejection fraction heart failure and cardiac resynchronization therapy, our study has shown that increase in narrowing QRS duration after cardiac resynchronization therapy implantation is associated with development in 6-minute walking distance.

Özet

Amaç: Kardiyak resenkronizasyon tedavisinin, elektriksel dissenkroniye bağlı azalmış ejeksiyon fraksiyonlu kalp yetmezliği olan hastalarda etkili olduğu kanıtlanmıştır. Bu çalışmanın amacı, kardiyak resenkronizasyon tedavisi sonrası QRS süresindeki daralma ile fonksiyonel kapasitenin bir göstergesi olan 6 dakikalık yürüme mesafesi ile arasındaki ilişkiyi incelemektir. Gereç ve Yöntem: Çalışmaya sol ventrikül ejeksiyon fraksiyonu ≤%35 olan kronik kalp yetmezliği ile takip edilen (%38 iskemik, %62 iskemik olmayan) toplam 39 semptomatik (New York Heart Association sınıf II-IV) hasta (24 kadın, 19 erkek) dahil edildi. Bulgular: Kardiyak resenkronizasyon tedavisi öncesine kıyasla, kardiyak resenkronizasyon tedavisi sonrası değerlendirmede QRS süresinde istatistiksel olarak anlamlı azalma (153.62 ± 8.49 ve 131.44 ± 9.86 msn, p <0.001) ve 6 dakikalık yürüme mesafesinde artış (247.77 ± 52.93 vs. 361.15 ± 66.17 m, p <0.001). QRS süresindeki daralma ile kardiyak resenkronizasyon tedavisi sonrası 6 dakikalık yürüme mesafesi arasında orta derecede negatif korelasyon (r = -0.52, p <0.001) tespit edildi. Sonuç: Çalışmamız, azalmış ejeksiyon fraksiyonlu kalp yetmezliği ve kardiyak resenkronizasyon tedavisi hastalarında, kardiyak resenkronizasyon tedavisi implantasyonu sonrası QRS süresindeki daralmanın 6 dakikalık yürüme mesafesindeki artış ile ilişkili olduğunu göstermiştir.

🔖

Cite This Article

EVLICE, M., AKCAKOYUN, M. (2021). The Relationship Between Narrowing Of The QRS Duration And Improvement In The 6-Minute Walking Distance After Cardiac Resynchronization Theraphy. Hitit Medical Journal, Cilt: 3 - Sayı: 1, 6–12. https://ajindex.com/articles/421131

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Heart and Stroke Statistical Update. Dallas, Texas: American Heart Association, 2000.
  2. Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., et al. (2002). Cardiac resynchronization in chronic heart failure. New England Journal of Medicine, 346(24), 1845-1853.
  3. Cazeau, S., Leclercq, C., Lavergne, T., Walker, S., Varma, C., Linde, C., et al. (2001). Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. New England Journal of Medicine, 344(12), 873-880.
  4. Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., et al. (2004). Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. New England Journal of Medicine, 350(21), 2140-2150.
  5. Cleland, J. G., Daubert, J. C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., et al. (2005). The effect of cardiac resynchronization on morbidity and mortality in heart failure. New England Journal of Medicine, 352(15), 1539-1549.
  6. Wasserman K, Hansen JE, Sue DY, Casaburi R, Whipp BJ. Principles of exercise testing and interpretation, 3rd edition. Philadelphia: Lippincott, Williams & Wilkins; 1999.
  7. Weisman IM, Zeballos RJ. An integrated approach to the interpretation of cardiopulmonary exercise testing. Clin Chest Med 1994;15:421–445.
  8. Woo M. A., Moser D. K., Stevenson L. W., Stevenson W. G.Six-minute walk test and heart rate variability: lack of association in advanced stages of heart failure. Am. J. Respir. Crit. Care Med. 61997348354 Cahalin L. P., Mathier M. A., Semigran M. J., Dec G. W., DiSalvo T. G.The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 1101996325332 Roul G., Germain P., Bareiss P. Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure? Am. Heart J. 1361998449457 Vidal B, Sitges M, Marigliano A, Delgado V, Diaz-Infante E, Azqueta M, et al. Optimizing the programmation of cardiac resynchronization therapy devices in patients with heart failure and left bundle branch block, Am J Cardiol, 2007, vol. 100 (pg. 1002-6)
  9. Shiota T, Jones M, Teien DE, Yamada I, Passafini A, Ge S, et al. Evaluation of mitral regurgitation using a digitally determined color Doppler flow convergence ‘centerline’ acceleration method. Studies in an animal model with quantified mitral regurgitation, Circulation, 1994, vol. 89 (pg. 2879-87). American S